BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26577943)

  • 1. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
    Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
    BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
    Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
    Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.
    Addo-Yobo E; Chisaka N; Hassan M; Hibberd P; Lozano JM; Jeena P; MacLeod WB; Maulen I; Patel A; Qazi S; Thea DM; Nguyen NT
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1141-8. PubMed ID: 15451221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
    Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
    BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
    JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Phiri M; Schmicker R; Hwang J; Ndamala CB; Phiri A; Lufesi N; May S
    N Engl J Med; 2020 Jul; 383(1):13-23. PubMed ID: 32609979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial.
    Vilas-Boas AL; Fontoura MS; Xavier-Souza G; Araújo-Neto CA; Andrade SC; Brim RV; Noblat L; Barral A; Cardoso MR; Nascimento-Carvalho CM;
    J Antimicrob Chemother; 2014 Jul; 69(7):1954-9. PubMed ID: 24648506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
    Atkinson M; Lakhanpaul M; Smyth A; Vyas H; Weston V; Sithole J; Owen V; Halliday K; Sammons H; Crane J; Guntupalli N; Walton L; Ninan T; Morjaria A; Stephenson T
    Thorax; 2007 Dec; 62(12):1102-6. PubMed ID: 17567657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial.
    Soofi S; Ahmed S; Fox MP; MacLeod WB; Thea DM; Qazi SA; Bhutta ZA
    Lancet; 2012 Feb; 379(9817):729-37. PubMed ID: 22285055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of enhancing audit and feedback on uptake of childhood pneumonia treatment policy in hospitals that are part of a clinical network: a cluster randomized trial.
    Ayieko P; Irimu G; Ogero M; Mwaniki P; Malla L; Julius T; Chepkirui M; Mbevi G; Oliwa J; Agweyu A; Akech S; Were F; English M;
    Implement Sci; 2019 Mar; 14(1):20. PubMed ID: 30832678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.
    Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group
    Lancet; 2002 Sep; 360(9336):835-41. PubMed ID: 12243918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2-59-month-old children: a cluster-randomised trial in Africa and Asia.
    EMPIC Study Group
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 34987033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.
    Hazir T; Qazi SA; Bin Nisar Y; Maqbool S; Asghar R; Iqbal I; Khalid S; Randhawa S; Aslam S; Riaz S; Abbasi S
    Arch Dis Child; 2007 Apr; 92(4):291-7. PubMed ID: 16547082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial.
    Mir F; Nisar I; Tikmani SS; Baloch B; Shakoor S; Jehan F; Ahmed I; Cousens S; Zaidi AK
    Lancet Glob Health; 2017 Feb; 5(2):e177-e185. PubMed ID: 27988146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial.
    Bari A; Sadruddin S; Khan A; Khan Iu; Khan A; Lehri IA; Macleod WB; Fox MP; Thea DM; Qazi SA
    Lancet; 2011 Nov; 378(9805):1796-803. PubMed ID: 22078721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review.
    Lodha R; Randev S; Kabra SK
    Indian Pediatr; 2016 Jun; 53(6):489-95. PubMed ID: 27376603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial.
    Ahmed S; Ariff S; Muhammed S; Rizvi A; Ahmed I; Soofi SB; Bhutta ZA
    J Glob Health; 2022 Dec; 12():04097. PubMed ID: 36579494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
    Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
    Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study.
    Addo-Yobo E; Anh DD; El-Sayed HF; Fox LM; Fox MP; MacLeod W; Saha S; Tuan TA; Thea DM; Qazi S;
    Trop Med Int Health; 2011 Aug; 16(8):995-1006. PubMed ID: 21545381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.
    Awasthi S; Agarwal G; Kabra SK; Singhi S; Kulkarni M; More V; Niswade A; Pillai RM; Luke R; Srivastava NM; Suresh S; Verghese VP; Raghupathy P; Lodha R; Walter SD
    PLoS One; 2008 Apr; 3(4):e1991. PubMed ID: 18431478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.